Monograph

J01DD01 - Cefotaxime

Propably not porphyrinogenic

Rationale

Metabolised only to a limited extent. No data pointing to CYP-interaction. Two references consider the drug safe.

Chemical description

Parenteral betalactamase stable cephalosporin used (1 g x 2) in various infections. Excreted in unchanged form (50-60 %), and as desacetyl derivative 15-25 %, by the kidneys within 24 hours. No data pointing to CYP interactions, South African list: use with caution. French list: safe.

Similar drugs

Explore alternative drugs in similar therapeutic classes J01D / J01DD or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Cefotaxim · Cefotaxim ERC 1000 mg, poeder voor oplossing voor injectie · Cefotaxim Eureco-Pharma 1 g, poeder voor oplossing voor injectie/infusie

Belgium

Cefotaxime · Cefotaxime Noridem 0.5 g sol. inj./perf. (pdr.) i.v. flac. · Cefotaxime Noridem 1 g sol. inj./perf. (pdr.) i.v. flac. · Cefotaxime Noridem 2 g sol. inj./perf. (pdr.) i.v. flac. · Claforan · Claforan 1 000 mg sol. inj. (pdr. + solv.) i.v./i.m. flac.

United Kingdom

Cefotaxime · Cefotaxime 1g powder for solution for injection vials · Cefotaxime 1g/50ml infusion bags · Cefotaxime 2g powder for solution for injection vials · Cefotaxime 2g/100ml infusion bags · Cefotaxime 500mg powder for solution for injection vials · Claforan · Claforan 1g powder for solution for injection vials · Claforan 2g powder for solution for injection vials · Claforan 500mg powder for solution for injection vials

Denmark